L 627

Known as: L-627 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2017
0102019922017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
The pharmacokinetics and tolerability of a new parenteral carbapenem antibiotic, biapenem (L-627), were studied in healthy… (More)
Is this relevant?
1994
1994
To conduct pharmacokinetic and clinical studies on newly developed L-627 (biapenem) against various infections in pediatrics, a… (More)
Is this relevant?
1994
1994
Biapenem (L-627) was evaluated for its safety and efficacy in 27 children with various bacterial infections. L-627 was effective… (More)
Is this relevant?
1994
1994
We tested 441 clinical strains of anaerobes by using a broth microdilution method to determine the in vitro activity of biapenem… (More)
  • table 1
Is this relevant?
1994
1994
Pharmacokinetic and clinical studies on biapenem (L-627), a newly developed carbapenem, were performed and the following results… (More)
Is this relevant?
1994
1994
UNLABELLED We investigated biapenem (BIPM, L-627) a newly carbapenem antibiotic, for its antibacterial activity, tissue… (More)
Is this relevant?
1993
1993
The in vitro activity of biapenem (formerly L-627 or LJC10, 627), a new carbapenem, was compared with that of imipenem and… (More)
Is this relevant?
1992
1992
The in vitro activity of L-627, a new parenterally administered carbapenem, was compared with those of imipenem, meropenem, FCE… (More)
Is this relevant?
1992
1992
The in vitro activity of L-627 against 370 anaerobic bacterial strains including anaerobic cocci,Propionibacterium acnes… (More)
  • table 3
  • table 1
Is this relevant?
1992
1992
MICs of two new carbapenems, meropenem and L-627, and imipenem were determined against 98 strains of the Nocardia asteroides… (More)
Is this relevant?